DNA ploidy and p-glycoprotein expression as predictive factors of response to neoadjuvant chemotherapy for invasive bladder cancer
- 30 June 1994
- Vol. 43 (6), 787-791
- https://doi.org/10.1016/0090-4295(94)90136-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Expression of the multidrug transporter, P-glycoprotein, in renal and transitional cell carcinomasCancer, 1993
- Deoxyribonucleic Acid Flow Cytometry in Invasive Bladder Carcinoma: A Possible Predictor for Successful Bladder Preservation following Transurethral Surgery and Chemotherapy-RadiotherapyJournal of Urology, 1992
- DNA Flow Cytometry and Neo-Adjuvant Chemotherapy/ Radiotherapy in Operable Muscle- Invasive Bladder CarcinomaEuropean Urology, 1992
- Deoxyribonucleic Acid Flow Cytometry in Predicting Response to Radical Radiotherapy of Bladder CancerJournal of Urology, 1990
- P-glycoproteins in pathology: The multidrug resistance gene family in humansHuman Pathology, 1990
- CMV chemotherapy for extensive urothelial carcinomaWorld Journal of Urology, 1988
- Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.Journal of Clinical Oncology, 1985
- Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the UrotheliumJournal of Urology, 1985
- Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.Journal of Histochemistry & Cytochemistry, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958